Citicoline (CDP-choline) labels should be read against the studies, not against the brightest claim on the bottle.
If you and your doctor decide to look at a product, read the label for the actual compound. It should say citicoline or CDP-choline. Cognizin is one branded form of that same compound, explained on its own page. A proprietary blend that hides the milligrams is a weaker label than one that states the dose.
Compare that number with doses used in studies, which ran about 250 to 2,000 mg a day depending on the trial. A label dose is not automatically the studied dose. Third-party testing, when a brand pays for it, is a check on what is in the bottle. It is not evidence that the ingredient treats a disease.
This is the only section of the site meant for product choice. Evidence pages do not carry affiliate links. Affiliate relationships, if they are added later, do not change a tier.
Structure and function talk has a legal ceiling. A supplement page must not say or imply that citicoline treats, cures, or prevents stroke, dementia, glaucoma, ADHD, or brain injury.
Questions for your doctor · Side effects · Evidence hub
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Citicoline (CDP-choline) sits in an unusual position. It has been tested in large, serious clinical trials for conditions like acute stroke and traumatic brain injury, yet in the United States it is sold as a dietary supplement, not an FDA-approved drug. That gap between the research setting and the store shelf is the most important thing to understand before you buy anything.
The largest stroke trial, published in The Lancet in 2012 (the ICTUS trial, with about 2,300 participants), found that citicoline did not improve 90-day recovery compared with placebo. Earlier and smaller meta-analyses had suggested benefit, but the biggest and most careful test did not confirm it. The largest trial in traumatic brain injury, the COBRIT trial published in JAMA in 2012, similarly found no improvement in functional or cognitive outcomes versus placebo. These results matter for shopping because they set the ceiling on what a label should imply. A bottle that hints at stroke recovery or brain injury repair is describing outcomes the best trials did not show.
Sudden facial droop, arm weakness, or speech difficulty can be a stroke. Call 911 immediately. No supplement is part of stroke care.
Where does that leave the ingredient? The evidence register is mixed but honest. A Cochrane review of chronic cerebrovascular cognitive decline found modest short-term benefit on memory and behaviour, while noting the trials were short and low in quality. An observational study in mild vascular cognitive impairment (the IDEALE study) associated citicoline use with stable scores, while an untreated group declined, but observational designs cannot prove cause. Small trials in glaucoma found changes on electrophysiological measures, without establishing any effect on vision loss. Small, industry-funded studies in healthy women and in adolescent males found better attention-test scores. For ADHD, there are no adequate trials at all, and there is no good evidence citicoline treats ADHD. The condition-by-condition breakdown lives on the evidence hub.
An honest citicoline label answers four questions without making you dig.
First, what is the compound? It should say citicoline or CDP-choline. Those are two names for the same molecule, as explained on the CDP-choline page. Cognizin is a branded, standardized form of that same compound, not a different molecule; the Cognizin page covers what the brand means and what it does not mean.
Second, how many milligrams per serving? This number should be printed plainly. Labels that list citicoline inside a "proprietary blend" tell you the blend total but not the citicoline amount. You cannot compare a hidden number to the doses used in studies.
Third, what is the suggested serving? Studies used roughly 250 to 2,000 mg a day, depending on the trial and the condition. That range is described on the dosage page. A label's suggested serving is a manufacturer's choice, not a medical recommendation, and it is not automatically the studied dose for any particular purpose.
Fourth, is there any third-party verification? Some brands pay independent laboratories to confirm identity and purity. Programs vary, but the general idea is the same: an outside party checked that the bottle contains what the label says, at the stated amount.
Third-party testing is worth having, but it answers a narrow question. It tells you the capsule contains citicoline in the amount claimed, and sometimes that common contaminants were screened for. That is a quality statement about the bottle in your hand.
It is not an efficacy statement. A perfectly pure capsule of citicoline is still an ingredient whose largest stroke and brain injury trials found no benefit over placebo, and whose positive findings come from smaller, shorter, or industry-funded studies. Purity and effectiveness are separate questions, and a testing seal addresses only the first one.
It is also not a complete guarantee. Testing usually applies to specific batches or to the ingredient a supplier provides. It does not mean every bottle ever shipped was re-analyzed. Treat a seal as a reasonable trust signal, not proof.
Certain patterns on a label or a product page should lower your confidence.
If you have two products in front of you, a simple order of operations helps.
1. Confirm the compound name on both: citicoline or CDP-choline. 2. Read the milligrams per serving on each. Compare like with like, per serving, not per container. 3. Note the number of servings per container so you can compare cost per day rather than sticker price. This page does not quote prices, because they change, but cost per day is the honest unit. 4. Check for third-party testing on each, and what the testing actually covered. 5. Read the rest of the label. Caffeine, herbs, or other actives change what the product is and what it might interact with.
If the two bottles are equivalent on those points, there is rarely a scientific reason to prefer one over the other. Brand preference, capsule size, and return policy become the deciding factors, and those are personal rather than medical.
It would be just as misleading to say citicoline does nothing as to say it does everything. The balanced reading of the register is this: the mechanism is plausible at the level of membrane phospholipid synthesis, though neuroprotective claims remain preclinical. Safety in trials was generally good at 250 to 2,000 mg a day, with mostly mild side effects such as stomach upset, headache, and insomnia, details on the side effects page. The positive human findings are real but rest on small, short, or industry-funded studies, and on one observational association. The negative findings come from the largest and most rigorous trials.
A cautious person weighing a purchase might reasonably decide that the safety profile is acceptable while holding modest expectations about benefit. That is a judgment to make with your doctor, especially if you take other medications. One interaction to raise specifically: citicoline may enhance the effects of levodopa, so people with Parkinson's disease should involve their neurologist before adding it. Pregnancy and breastfeeding data are lacking, which is itself a reason to pause and ask rather than assume. The questions for your doctor page is built for exactly that conversation.
You will notice this page does not point you to a specific brand. That is deliberate. The evidence pages on this site carry no affiliate links, and grading on those pages cannot be influenced by commercial relationships, now or later. If affiliate relationships are added to this section in the future, they will not change a single evidence tier, because the tiers live on the evidence pages and follow the trials.
The site's job is to give you the comparison method and the honest evidence summary, then step back. Your doctor's job is to tell you whether citicoline makes sense for you at all. A retailer's job is to sell you a bottle. Keeping those three jobs separate is the point.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Citicoline or CDP-choline. They are the same compound. Cognizin is a brand of it.
No. It speaks to identity and purity of what was tested, not to disease treatment.
Ask your doctor. Studies used roughly 250 to 2,000 mg a day. This page does not pick one for you.
No. Grading stays on the evidence pages, which do not link to products.
No. There is no own-label product.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
This site reports what studies found. It does not choose a dose for you.